Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3220154
Max Phase: Preclinical
Molecular Formula: C22H22O
Molecular Weight: 302.42
Molecule Type: Small molecule
Associated Items:
ID: ALA3220154
Max Phase: Preclinical
Molecular Formula: C22H22O
Molecular Weight: 302.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1C2(CCCC13CC3c1ccccc1)CC2c1ccccc1
Standard InChI: InChI=1S/C22H22O/c23-20-21(14-18(21)16-8-3-1-4-9-16)12-7-13-22(20)15-19(22)17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2
Standard InChI Key: HERAKZWCCNYPAM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 302.42 | Molecular Weight (Monoisotopic): 302.1671 | AlogP: 5.09 | #Rotatable Bonds: 2 |
Polar Surface Area: 17.07 | Molecular Species: | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.60 | CX LogD: 5.60 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.76 | Np Likeness Score: 0.63 |
1. Tripathi RP, Pandey J, Kukshal V, Ajay A, Mishra M, Dube D, Chopra D, Dwivedi R, Chaturvedi V, Ramachandran R. (2011) Synthesis, in silico screening and bioevaluation of dispiro-cycloalkanones as antitubercular and mycobacterial NAD+-dependent DNA ligase inhibitors, 2 (5): [10.1039/C0MD00246A] |
Source(1):